AC IMMUNE SA Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019
AC IMMUNE SA (ACIU) reported Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 of $2.40 per share for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-13.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 · last filed 2026-03-13
CHF
| Period end | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 12 month |
|---|---|
| 2020-12-31 | 6.29 CHF 20-F · filed 2021-03-23 |
| 2019-12-31 | 5.24 CHF 20-F · filed 2021-03-23 |
| 2018-12-31 | 9.79 CHF 20-F · filed 2021-03-23 |
| 2017-12-31 | 9.70 CHF 20-F · filed 2020-03-30 |
USD/shares
| Period end | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 12 month |
|---|---|
| 2025-12-31 | $2.40 20-F · filed 2026-03-13 |
| 2024-12-31 | $3.99 20-F · filed 2026-03-13 |
| 2023-12-31 | $2.08 20-F · filed 2026-03-13 |
| 2022-12-31 | $3.44 20-F · filed 2025-03-13 |
| 2021-12-31 | $6.95 20-F · filed 2024-03-14 |
| 2020-12-31 | $7.11 20-F · filed 2023-03-16 |
| 2019-12-31 | $5.41 20-F · filed 2022-03-22 |
| 2018-12-31 | $9.97 20-F · filed 2021-03-23 |
CHF/shares
| Period end | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 12 month |
|---|---|
| 2025-12-31 | 2.09 CHF/shares 20-F · filed 2026-03-13 |
| 2024-12-31 | 3.40 CHF/shares 20-F · filed 2026-03-13 |
| 2023-12-31 | 1.75 CHF/shares 20-F · filed 2026-03-13 |
| 2022-12-31 | 3.18 CHF/shares 20-F · filed 2025-03-13 |
| 2021-12-31 | 6.34 CHF/shares 20-F · filed 2024-03-14 |
| 2020-12-31 | 6.29 CHF/shares 20-F · filed 2023-03-16 |
| 2019-12-31 | 5.24 CHF/shares 20-F · filed 2022-03-22 |
| 2018-12-31 | 9.79 CHF/shares 20-F · filed 2021-03-23 |
| 2017-12-31 | 9.70 CHF/shares 20-F · filed 2020-03-30 |